NLS Pharmaceutics regains compliance with Nasdaq

NLS Pharmaceutics ( NASDAQ: NLSP ) said it has received notice from the Nasdaq, stating that the firm has regained full compliance with the bid price requirement. Press Release More on NLS Pharmaceutics Seeking Alpha’s Quant Rating on NLS Pharmaceutics Historical earnings data for NLS Pharmaceutics.